Juvenile haemochromatosis (JH) is an autosomal recessive disorder whic
h leads to early-onset, severe iron overload. The disease affects both
sexes equally. Iron parameters and tissue iron distribution are simil
ar to those in middle-life haemochromatosis (which is linked to the HF
E gene). Endocrine manifestations, especially hypogonadism, and heart
failure are the most prominent clinical features. Liver involvement, a
lthough present, is clinically less relevant. Genetic evidence indicat
es that JH is a disorder distinct from HFE-linked disease. Patients do
not have mutations in the HFE gene, and the study of selected familie
s has excluded a linkage to the interval of chromosome 6p where the HF
E gene resides. The distinction between the two disorders raises the p
ossibility that the different clinical presentation of JH is not only
age-related but probably depends on a different biochemical defect. Ea
rly diagnosis of JH is important to avoid cardiac complications which
can lead to premature death. As with HFE-linked disease, JH is respons
ive to phlebotomies.